• Citer

HER2 expression and HER2:HER2 dimerization identifies subpopulations of metastatic breast cancer patients with different probabilities of long-term survival following trastuzumab treatment and with different requirements for concomitant chemotherapy.

par Bates, B;Desmedt, Christine ;Sperinde, Jeff;Huang, Weidong;Larsimont, Denis ;Durbecq, Virginie ;Winslow, John;Chappey, Colombe;Petropoulos, Christos;Sotiriou, Christos
Référence ASCO(June 2007: Chicago, Il USA), Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, Vol. 25
Publication Publié, 2007-06

Abstract de conférence

• Détails
• Contenu

Titre:	HER2 expression and HER2:HER2 dimerization identifies subpopulations of metastatic breast cancer patients with different probabilities of long-term survival following trastuzumab treatment and with different requirements for concomitant chemotherapy.
Auteur:	Bates, B; Desmedt, Christine; Sperinde, Jeff; Huang, Weidong; Larsimont, Denis; Durbecq, Virginie; Winslow, John; Chappey, Colombe; Petropoulos, Christos; Sotiriou, Christos
Informations sur la publication:	ASCO(June 2007: Chicago, Il USA), Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, Vol. 25
Statut de publication:	Publié, 2007-06
Sujet CREF:	Sciences bio-médicales et agricoles
	Médecine pathologie humaine
	Cancérologie
Langue:	Anglais